SV Health Investors is a venture capital firm in Massachusetts that focuses on biotechnology and healthcare industry. Founded 1993 in Boston, Massachusetts, United States, it invests in debt, early stage ventures, late stage ventures, series B, series A, and series D rounds. Its portfolio companies include Xilio Therapeutics, EBT Medical, Ervaxx, Healthify, Clarify Medical, Bardy Diagnostics, CSA Medical, Rheostat Therapeutics, Ribometrix, and Urgent Team Holdings, Inc. As of April 2020, SV Health Investors has made 216 investments. Their most recent investment was on March 2, 2020, when Xilio Therapeutics raised $100.5M. V Health Investors has had 38 exits, the most notable of which include Bicycle Therapeutics, Avrobio, and Sutro Biopharma. The company has raised seven funds, their latest being SV7 Growth Fund.
Timeline
Funded Companies
Healthify is a company founded by Manik Bhat, Eric Allen Conner, Daniel Levenson and Alex Villa.
Developing gene therapies to potentially cure rare diseases.
Evidation Health is a health and measurement company providing technical support to biopharmaceutical and healthcare companies.
A company focused on devloping human monoclonal and bispecific antibodies for oncology, immunomodulation, inflammation, neuroscience and pain
A company developing hemodynamic monitoring solutions to detect heart failure
A biopharmaceutiical company discovering, developing and manufacturing therapeutics for the treatment of canccer
California Institute for Quantitative Biosciences is a California-based biotechnology company founded in 2000. It is a partnership between Venture Capital, California State, Private Industry, University of California Campuses Berkeley, San Francisco and Santa Cruz.
Iveric Bio develops therapies for patients suffering from rare retinal diseases.
A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases
Pionyr Immunotherapeutics is a San Francisco-based biotechnology company and developer of cancer immunotherapies designed to target the tumor microenvironment.
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
A pharmaceutical company that develops topical eye drops for the treatment of eye diseases
A biopharmaceutical company developing therapeutics for skin disorders
A pharmaceutical company focused to develop anti-infective medicines
A company that develops cell therapies to treat kidney diseases
A company developing cancer therapeutics
CardioKinetix is a Menlo Park, California-based company.
Ribometrix is a Carrboro, North Carolina-based company.
Panoptica is a company founded by Evgeniy Grahev.
Associated investment funds
People
David Milne
Managing Partner
Jacqueline Grant
Senior Associate
Michael Balmuth
Managing Partner
Further reading
Documentaries, videos and podcasts
Companies
EBT Medical
Ervaxx
Healthify
Xilio Therapeutics